Cargando…
SARS-CoV-2 infection in alpha1-antitrypsin deficiency
Alpha1-antitrypsin deficiency arises due to mutations in alpha1-antitrypsin (AAT) gene and represents the most prominent genetic predisposition to chronic obstructive pulmonary disease and emphysema. Since AAT plays important immunomodulatory and tissue-protective roles and since it was suggested to...
Autores principales: | Schneider, Carolin V., Strnad, Pavel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116136/ https://www.ncbi.nlm.nih.gov/pubmed/34010739 http://dx.doi.org/10.1016/j.rmed.2021.106466 |
Ejemplares similares
-
Is SARS-COV-2 associated with alpha-1 antitrypsin deficiency?
por: Rodríguez-García, Carlota, et al.
Publicado: (2023) -
The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients
por: Sark, Annelot D., et al.
Publicado: (2022) -
Alpha-1 antitrypsin as a risk marker in SARS-CoV-2 infection
por: Hernández Pérez, José María, et al.
Publicado: (2021) -
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
por: Wettstein, Lukas, et al.
Publicado: (2021) -
Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2
por: Azouz, Nurit P., et al.
Publicado: (2020)